Articles

Sagar Lonial, MD, FACP, discusses the approval of belantamab mafodotin-blmf and how it addressed an unmet need in relapsed/refractory multiple myeloma.

Novel Combos With Belantamab Mafodotin May Move the Needle in Myeloma

Videos

Nabil F. Saba, MD, FACP, discusses ​scheduling challenges with cisplatin in head and neck cancer.  



Dr. Saba on Scheduling Challenges With Cisplatin in Head and Neck Cancer 

Nabil F. Saba, MD, FACP, discusses ​emerging sequencing ​strategies in head and neck cancer. 

Dr. Saba on Emerging Sequencing Strategies in Head and Neck Cancer 

Sagar Lonial, MD, FACP, discusses the FDA approval of belantamab mafodotin in patients with relapsed/refractory multiple myeloma. 



Dr. Lonial on the FDA Approval of Belantamab Mafodotin-blmf in Multiple Myeloma

Nabil F. Saba, MD, FACP, discusses the future of treatment in head and neck cancer.



Dr. Saba on the Future of Treatment in Head and Neck Cancer 

Sagar Lonial, MD, FACP, discusses the benefits of early intervention in high-risk smoldering multiple myeloma.

Winship

Latest from Winship

New content coming soon, please check back later.